Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Eyepoint Pharmaceuticals Inc (EYPT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Eyepoint Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
20.940 -0.900    -4.12%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
20.940
-0.000
-0.000%
16:20:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 424,395
  • Bid/Ask: 20.600 / 21.970
  • Day's Range: 20.850 - 22.020
Eyepoint Pharma 20.940 -0.900 -4.12%

Eyepoint Pharma (EYPT) Earnings Dates & Reports

 
On this page, you can find detailed information about the financial performance of pSivida, including the latest pSivida earnings report and upcoming earnings date. The page provides an overview of the company's financial health, with key data points such as the current stock price, earnings per share, and revenue compared against the forecast.
InvestingPro Earnings Insights
Latest Release

Mar 07, 2024

EPS / Forecast

-0.33 / -0.49

Revenue / Forecast

14.03M / 8.88M

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Jul 31, 2024 06/2024 -- /  -0.4388 -- /  9.66M
May 01, 2024 03/2024 -- /  -0.3963 -- /  9.78M
Mar 07, 2024 12/2023 -0.33 /  -0.49 14.03M /  8.88M
Nov 01, 2023 09/2023 -0.33 /  -0.5 15.2M /  7.86M
Aug 02, 2023 06/2023 -0.61 /  -0.69 9.1M /  79.11M
May 03, 2023 03/2023 -0.56 /  -0.67 7.39M /  7.91M
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View upcoming earnings forecasts and in-depth analysis of company forecasts.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EYPT Comments

Write your thoughts about Eyepoint Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
John Johnson
John Johnson Aug 22, 2023 1:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
20?
matanel liberman
matanel liberman Jul 28, 2023 2:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
14 soon
matanel liberman
matanel liberman Jul 08, 2023 6:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
10 soon
Joe Jordan
Joe Jordan Apr 23, 2023 1:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
EyePoint Pharmaceuticals was initiated with an Outperform rating and $33 per share price target at Baird on Friday, pushing its share price significantly higher ($9)
Tamara AMAL
Tamara AMAL Apr 23, 2023 1:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what's going on with Egypt,???
Tamara AMAL
Tamara AMAL Apr 23, 2023 1:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what's going on, dipping?
Joe Jordan
Joe Jordan Nov 18, 2021 6:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
EyePoint Pharma secures $100M capital raise via equity offering
Joe Jordan
Joe Jordan Nov 16, 2021 1:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yesterday value moved from 14.0 to 21.5 and during the day moved back to 14.3 dollars
Joe Jordan
Joe Jordan Nov 16, 2021 1:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Shares of EyePoint Pharmaceuticals Inc. reached a new 52-week intraday high after the company reported positive data from its Phase 1 DAVIO study of EYP-1901 in Wet AMD and announced plans to move forward to additional Phase 2 clinical trials in 2022.
Joe Jordan
Joe Jordan Feb 13, 2021 6:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any possible target price?
Joe Jordan
Joe Jordan Jan 04, 2021 5:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you reckon can come back to 20 USD?
Marcos Remy
Marcos Remy Jan 04, 2021 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What h?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email